Refereed journal article or data article (A1)

The CJEU broadens the scope of European SPCs, but shortens validity of its duration in certain Member States




List of Authors: Daniel Acquah

Publisher: Oxford University Press

Place: Oxford

Publication year: 2017

Journal: Journal of Intellectual Property Law and Practice

Journal acronym: JIPLP

Volume number: 12

Issue number: 4

Number of pages: 2

ISSN: 1747-1532

eISSN: 1747-1540

DOI: http://dx.doi.org/10.1093/jiplp/jpx016

URL: https://academic.oup.com/jiplp/article/12/4/263/3065362/The-CJEU-broadens-the-scope-of-European-SPCs-but

Self-archived copy’s web address: https://research.utu.fi/converis/portal/detail/Publication/19260413


Abstract

The Court of Justice of the European Union (CJEU) has clarified that, where a medicinal product has been the subject of a marketing authorization (MA) within the European Economic Area (EEA), before that granted in a Member State of the European Union (EU), and even before the Member State’s accession to the EU, the EEA MA must be taken into account for the purpose of determining the duration of the supplementary protection certificate granted in the EU.


Downloadable publication

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.




Last updated on 2022-07-04 at 16:25